These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38927590)

  • 41. [Clinical and genetic characteristics of 21 children with Rubinstein-Taybi syndrome].
    Yang SH; Liu HR; Li JY; Zhang Y; Liu ZQ; Wang L; Chen XL; Shangguan SF
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):351-356. PubMed ID: 38527506
    [No Abstract]   [Full Text] [Related]  

  • 42. First case of Rubinstein-Taybi syndrome with desquamation associated with a novel mutation in the bromodomain of the CREBBP gene.
    Wang L; Deng Y; Zhou XL; Ma JJ; Li W
    Clin Exp Dermatol; 2019 Jul; 44(5):e205-e208. PubMed ID: 30614040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rubinstein-Taybi syndrome.
    Kosaki R
    Nihon Rinsho; 2017 Mar; 75(3):498-503. PubMed ID: 30566799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unusual prenatal presentation of Rubinstein-Taybi syndrome: a case report.
    Bedeschi MF; Crippa BL; Colombo L; Guez S; Cerruti M; Fogliani R; Gervasini C; Lalatta F
    Am J Med Genet A; 2014 Oct; 164A(10):2663-6. PubMed ID: 25073882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement.
    Lacombe D; Bloch-Zupan A; Bredrup C; Cooper EB; Houge SD; García-Miñaúr S; Kayserili H; Larizza L; Lopez Gonzalez V; Menke LA; Milani D; Saettini F; Stevens CA; Tooke L; Van der Zee JA; Van Genderen MM; Van-Gils J; Waite J; Adrien JL; Bartsch O; Bitoun P; Bouts AHM; Cueto-González AM; Dominguez-Garrido E; Duijkers FA; Fergelot P; Halstead E; Huisman SA; Meossi C; Mullins J; Nikkel SM; Oliver C; Prada E; Rei A; Riddle I; Rodriguez-Fonseca C; Rodríguez Pena R; Russell J; Saba A; Santos-Simarro F; Simpson BN; Smith DF; Stevens MF; Szakszon K; Taupiac E; Totaro N; Valenzuena Palafoll I; Van Der Kaay DCM; Van Wijk MP; Vyshka K; Wiley S; Hennekam RC
    J Med Genet; 2024 May; 61(6):503-519. PubMed ID: 38471765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and mutational spectrum in Korean patients with Rubinstein-Taybi syndrome: the spectrum of brain MRI abnormalities.
    Lee JS; Byun CK; Kim H; Lim BC; Hwang H; Choi JE; Hwang YS; Seong MW; Park SS; Kim KJ; Chae JH
    Brain Dev; 2015 Apr; 37(4):402-8. PubMed ID: 25108505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome.
    Bartsch O; Labonté J; Albrecht B; Wieczorek D; Lechno S; Zechner U; Haaf T
    Am J Med Genet A; 2010 Jan; 152A(1):181-4. PubMed ID: 20014264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic and germ-line mosaicism in Rubinstein-Taybi syndrome.
    Chiang PW; Lee NC; Chien N; Hwu WL; Spector E; Tsai AC
    Am J Med Genet A; 2009 Jul; 149A(7):1463-7. PubMed ID: 19533794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exome sequencing identifies a novel EP300 frame shift mutation in a patient with features that overlap Cornelia de Lange syndrome.
    Woods SA; Robinson HB; Kohler LJ; Agamanolis D; Sterbenz G; Khalifa M
    Am J Med Genet A; 2014 Jan; 164A(1):251-8. PubMed ID: 24352918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for partial deletions in the CREBBP gene in Rubinstein-Taybi syndrome patients using multiplex PCR/liquid chromatography.
    Udaka T; Kurosawa K; Izumi K; Yoshida S; Tsukahara M; Okamoto N; Torii C; Kosaki R; Masuno M; Hosokai N; Takahashi T; Kosaki K
    Genet Test; 2006; 10(4):265-71. PubMed ID: 17253932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic mechanisms of Rubinstein-Taybi syndrome.
    Park E; Kim Y; Ryu H; Kowall NW; Lee J; Ryu H
    Neuromolecular Med; 2014 Mar; 16(1):16-24. PubMed ID: 24381114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome.
    Wild KT; Nomakuchi TT; Sheppard SE; Leavens KF; De León DD; Zackai EH
    Am J Med Genet A; 2021 Apr; 185(4):1251-1255. PubMed ID: 33442921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
    Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
    Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.
    López M; Seidel V; Santibáñez P; Cervera-Acedo C; Castro-de Castro P; Domínguez-Garrido E
    BMC Med Genet; 2016 Dec; 17(1):97. PubMed ID: 27964710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of a large Rubinstein-Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain.
    Cross E; Duncan-Flavell PJ; Howarth RJ; Hobbs JI; Thomas NS; Bunyan DJ
    Am J Med Genet A; 2020 Nov; 182(11):2508-2520. PubMed ID: 32827181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptome and acetylome profiling identify crucial steps of neuronal differentiation in Rubinstein-Taybi syndrome.
    Van Gils J; Karkar S; Barre A; Ley-Ngardigal S; Nothof S; Claverol S; Tokarski C; Trani JP; Chevalier R; Broucqsault N; El Yazidi C; Lacombe D; Fergelot P; Magdinier F
    Commun Biol; 2024 Oct; 7(1):1331. PubMed ID: 39407026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients.
    Stef M; Simon D; Mardirossian B; Delrue MA; Burgelin I; Hubert C; Marche M; Bonnet F; Gorry P; Longy M; Lacombe D; Coupry I; Arveiler B
    Eur J Hum Genet; 2007 Aug; 15(8):843-7. PubMed ID: 17473832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germline mosaicism in Rubinstein-Taybi syndrome.
    Tajir M; Fergelot P; Lancelot G; Elalaoui SC; Arveiler B; Lacombe D; Sefiani A
    Gene; 2013 Apr; 518(2):476-8. PubMed ID: 23352794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.
    Sharma N; Mali AM; Bapat SA
    J Biosci; 2010 Jun; 35(2):187-202. PubMed ID: 20689175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300.
    Bartholdi D; Roelfsema JH; Papadia F; Breuning MH; Niedrist D; Hennekam RC; Schinzel A; Peters DJ
    J Med Genet; 2007 May; 44(5):327-33. PubMed ID: 17220215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.